Actinomycetes scale-up for the production of the antibacterial, nocathiacin

Biotechnology Progress

Volumn 25, Issue 1, 2009, Pages 176-188

  Junker, Beth ^a   Walker, Andre ^a   Hesse, Michelle ^a   Lester, Mike ^a   Christensen, Jens ^a   Connors, Neal ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Amycolatopsis; Antibacterial; Fermentation; Pilot scale; Scale up; Secondary metabolite

Indexed keywords

AMYCOLATOPSIS; ANTIBACTERIAL; PILOT-SCALE; SCALE-UP; SECONDARY METABOLITE;

AERODYNAMICS; AMMONIUM COMPOUNDS; CELL CULTURE; DRUG PRODUCTS PLANTS; FERMENTATION; FLOW OF GASES; FLOW RATE; GASES; GLUCOSE; METABOLISM; METABOLITES; ORGANIC POLYMERS; OXYGEN; SODIUM COMPOUNDS; STERILIZATION (CLEANING);

BIOCHEMICAL ENGINEERING;

ACTINOBACTERIA; ACTINOBACTERIA (CLASS); AMYCOLATOPSIS; AMYCOLATOPSIS FASTIDIOSA;

ANTIINFECTIVE AGENT; NOCATHIACIN I; PEPTIDE;

ACTINOBACTERIA; ARTICLE; FERMENTATION; GROWTH, DEVELOPMENT AND AGING; KINETICS; METABOLISM; METHODOLOGY; MICROBIOLOGY;

ACTINOBACTERIA; ANTI-BACTERIAL AGENTS; FERMENTATION; INDUSTRIAL MICROBIOLOGY; KINETICS; PEPTIDES;

EID: 64549147175     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1002/btpr.122     Document Type: Article

References (60)

1. Alvarez M. A strain of Nocardia mediterranei that produces a mixture of rifamycin B and W. Biotechnol Lett. 1990;12:283-288.
2. Anonymous. Medical affairs management key to good business. Drug Discov News 2007;3:3.
3. Bapat PM, Bhartiya S, Venkatesh KV, Wangikar PP. Structured kinetic model to represent the utilization of multiple substrates in complex media during rifamycin B fermentation. Biotechnol Bio- eng. 2005;93:779-790.
4. Bapat PM, Das D, Dave NN, Wangikar PP. Phase shifts in the stoi- chiometry of rifamycin B fermentation and correlation with the trends in the parameters measured online. J Biotechnol. 2006;127:115-128.
5. Bapat PM, Wangikar PP. Optimization of rifamycin B fermentation in shake flasks via a machine-learning-based approach. Biotechnol Bioeng. 2004;86:201-208.
6. Benz GT. Piloting bioreactors for agitation scale-up. Chem Eng Prog. 2008;104:32-34.
7. o J Ind Microbiol. 1989;4:247-252.
8. Brana AF, Demain AL. Nitrogen control of antibiotic biosynthesis in actinomycetes. In: Sanchez-Esquivel S, editor. Nitrogen Source Control of Microbial Processes. Boca Raton, FL: CRC Press; 1988:99-119.
9. Bylinkina ES, Birukov VV. The problem of antibiotic synthesis. Proc IV IFS: Ferment Technol Today 1972:104-115.
10. Cane DE, Walsh CT, Khosla C. Harnessing the biosynthetic code: combinations, permutations, and mutations. Science. 1998;282:63-68.
11. Chary CVK, Rambhav S, Venkateswerlu G, Ramachandran LK. Possible precursors for thiostrepton in Streptomyces azureus. Indian J Microbiol. 1989;29:191-198.
12. Cover WH, Kirpekar AC, George H, Stieber RW. Calcium inhibition of efrotomycin production by Nocardia lactamdurans. J Ind Microbiol. 1991;7:41-44.
13. Dahod SK. Dissolved carbon dioxide measurement and its correlation with operating parameters in fermentation processes. Biotech-nol Prog. 1993;9:655-660.
14. Davies JL, Baganz F, Ison AP, Lye GJ. Studies on the interaction of fermentation and microfiltration operations: erythromycin recovery from Saccharopolyspora erythraea fermentation broths. Biotechnol Bioeng. 2000;69:429-439.
15. El-Tayeb OM, Hussein MMM, Salama AA, El-Sedawy HF. Optimization of industrial production of rifamycin B by Amycolatopsis mediterranei. IV. Production in the fermentor. African J Biotechnol. 2004;3:432-440.
16. Ettler P. Problems and possibilities in fermentation scale-up procedure. In: Malik VS, Sridhar P, editors. Industrial Biotechnology. New Delhi, India: Oxford and IBH; 1992:297-305.
17. Frick R, Junker B. Indirect methods for characterization of carbon dioxide levels in fermentation broth. J Biosci Bioeng. 1999; 87:344-351.
18. Houck DR, Chen LC, Keller PJ, Beale JM, Floss HG. Biosynthesis of the modified peptide antibiotic nosiheptide in Streptomyces actuosus. J Am Chem Soc. 1988;110:5800-5806.
19. Jain D, Buckland B. Scale-up of the efrotomycin fermentation using a computer-controlled pilot plant. Bioprocess Eng. 1988;3:31-36.
20. Jain D, Nielsen JBK, Buckland B. Kinetics of efrotomycin synthesis in a synthetic fermentation medium. Bioprocess Eng. 1992;7:257-263.
21. Jayasuriya H, Herath K, Ondeyka JG, Zhang C, Zink DL, Brower M, Gailliot FP, Greene J, Birdsall G, Venugopal J, Ushio M, Burgess B, Russotti G, Walker A, Hesse M, Seeley A, Junker B, Connors N, Salazar O, Genilloud O, Kun L, Masurekar P, Barrett JF, Sing SB. Isolation and structure elucidation of thiazomycin- a potent thiazolyl peptide antibiotic from Amycolatopsis fastid- iosa. J Antibiot. 2007;60:554-564.
22. Jin, ZH, Cen PL. Improved production of spiramycin by mutant Streptomyces ambofaciens. J Zhejiang Univ Sci. 2004;5:689-695.
23. Jin ZH, Lin JP, Xu ZN, Cen PL. Improvement of industry-applied rifamycin B-producing strain, Amycolatopsis mediterranei,by rational screening. J Gen Appl Microbiol. 2002;48:329-334.
24. 2+ supplementation augments vancomycin production by Amycolatopsis orien- talis. Biotechnol Lett. 2002;24:293-296.
25. Jung HM, Kim SY, Moon HJ. Optimization of culture conditions and scale-up to pilot and plant scales for vancomycin production by Amycolatopsis orientalis. Appl Microbiol Biotechnol. 2007;77: 789-795.
26. Junker B. Foam and its mitigation in fermentation systems. Biotech- nol Prog. 2007;23:767-784.
27. Junker B, Seeley A, Mann Z, Lester M, Kovatch M, Schmitt J, Bor- ysewicz S, Lynch J, Zhang J, Greasham R. Use of bagged seed for secondary metabolite and bioconversion processes at the pilot scale. Biotechnol Bioeng. 2002;79:628-640.
28. Junker BH, Hesse M, Burgess B, Masurekar P, Connors N, Seeley A. Early phase process scale up challenges for fungal and filamentous bacterial cultures. Appl Biochem Biotechnol. 2004;119: 241-277.
29. Junker BH, Mann Z, Gailliot P, Byrne PK, Wilson J. Use of soybean oil and ammonia additions to optimize secondary metabolite production. Biotechnol Bioeng. 1998b;60:580-588.
30. Junker BH, Reddy J, Olewinski R, Gailliot P, Byrne K, Gbewonyo K. Secondary metabolite scale-up to minimize homolog impurity
31. levels. Biotechnol Bioeng. 1998a;59:595-604.
32. Kirpekar AC, Kirwan DJ, Stieber RW. Effects of glutamate, glucose, phosphate, and alkali metal ions on cephamycin C production by Nocardia lactamdurans in defined media. Biotechnol Bioeng. 1991;38:1100-1109.
33. Krishna PSM, Venkateswartu G, Rao LV. Studies on fermentative production of rifamycin using Amycolatopsis mediterranei. World J Microbiol Biotechnol. 1998;14:689-691.
34. Lancini GC. Fermentation and biosynthesis of glycopeptides antibiotics. In: Bushell ME, Grafe U, editors. Bioactive Metabolites from Microorganisms. Amsterdam: Elsevier Science Publishers BV; 1989:283-296.
35. Lee JG, Choi CY, Seong BL, Han MH. Optimal pH profile in rifamycin B fermentation. J Ferment Technol. 1983;61:49-53.
36. Leet JE, Li W, Ax HA, Matson JA, Huang S, Huang R, Cantone JL, Drexler D, Dalterio RA, Lam KS. Nocathiacins, new thiazolyl peptide antibiotics from Nocardia sp. II. Isolation, characterization, and structure determination. J Antibiot. 2003;56:232-242.
37. Li W, Leet JE, Ax HA, Gustavson DR, Brown DM, Turner L, Brown K, Clark J, Yang H, Fung-Tomc J, Lam KS. Nocathiacins, new thiazolyl peptide antibiotics from Nocardia sp. I. Taxonomy, fermentation, and biological activities. J Antibiot. 2003;56:226-231.
38. Liao X, Vining LC, Doull JL. Physiological control of trophophase- idiophase separation tin streptomycete cultures producing secondary metabolites. Can J Microbiol. 1995;41:309-315.
39. Lilly MD. Problems in process scale-up. In: Nisbet LJ, editor. Bio- active Microbial Products, Vol. 2. London: Academic Press; 1984:79-89.
40. Mertz FP, Doolin LE. The effect of inorganic phosphate on biosynthesis of vancomycin. Can J Microbiol. 1973;19:263-270.
41. Minas W, Briinker P, Kallio PT, Bailey JE. Improved erythromycin production in a genetically engineered industrial strain of Saccha- ropolyspora erythraea. Biotechnol Prog. 1998;14:561-566.
42. Mocek U, Zhaopie Z, O'Hagan D, Zhou P, Duen L, Fan G, Beale JM, Floss HG. Biosynthesis of the modified peptide antibiotic thiostrepton in Streptomyces azureus and Streptomyces laurentii. J Am Chem Soc. 1993;115:7992-8001.
43. Nash CH III. Effect of carbon dioxide on synthesis of erythromycin. Antimicrob Agents Chemother. 1974;5:544-545.
44. Nesbit EA, Gunasekaran M. Influence of cultural conditions on growth and lipolytic activity in Nocardia asteroides. Folia Micro- biol. 1993;38:451-455.
45. Okada S, Iwamatu S. Scale-up production of milbemycin by Strep- tomyces hygroscopicus subsp. aureolacrimosus with control of internal pressure, temperature, aeration and agitation. J Chem Technol Biotechnol. 1997;70:179-187.
46. Okumura M, Fujinaga K, Seike Y, Honda S. A simple and rapid visual method for the determination of ammonia nitrogen in environmental waters using thymol. Frensenius J Anal Chem. 1999; 365:467-469.
47. Onken U, Liefke E. Effect of total and partial pressure (oxygen and carbon dioxide) on aerobic microbial processes. In: Fiechter A, editor. Advances in Biochemical Engineering/Biotechnology, Vol. 40. Berlin: Springer-Verlag; 1989:138-169.
48. Platas G, Moron R, Gonzalez I, Collado J, Genilloud O, Peláez F, Diez MT. World J Microbiol Biotechnol. 1998;14:521-527.
49. Platt TB, Frazier WR. Effect of metal cations on production of thio- strepton. Antimicrob Agents Chemother. 1961;1:205-211.
50. Pucci MJ, Bronson JJ, Barrett JF, DenBleyker KL, Discotto LF, Fung-Tomc JC, Ueda Y. Antimicrobial evaluation of nocathia- cins, a thiazole peptide class of antibiotics. Antimicrob Agents Chemother. 2004;48:3697-3701.
51. Roman RV, Gavrilescu M. Oxygen transfer efficiency in the biosynthesis of antibiotics in bioreactors with a modified rushton turbine agitator. Acta Biotechnol. 1994;14:181-192.
52. Sensi P, Thiemann JE. Production of rifamycins. Prog Ind Micro- biol. 1967;6:21-60.
53. Singh SB, Occi J, Jayasuriya H, Herath K, Motyl M, Dorso K, Gill, Hickey E, Overbye KM, Barrett JF, Masurekar P. Antibacterial evaluations of thiazomycin-a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosa. J Antibiot. 2007;60:565-571.
54. Szarka L, Magyar K. The foams of fermentation broths. I. Some parameters of the foaming of fermentation media. Biotechnol Bioeng. 1969;11:701-710.
55. Takebe H, Takane N, Hiruta O, Satoh A, Kataoka H, Tanaka H. Scale-up of bialaphos production. J Ferment Bioeng. 1994;78:93-99.
56. Venkateswarlu G, Krishna PSM, Pandey A, Rao V. Evaluation of Amycolatopsis mediterranei VA18 for production of rifamycin B. Process Biochem. 2000;36:305-309.
57. Virgillio A, Marcelli E, Agrimino A. Aeration-agitation studies on the rifamycin fermentation. Biotechnol Bioeng. 1964;6:271-283.
58. Warr SRC, Gershater CJL, Box SJ. Seed stage development for improved fermentation performance: increased milbemycin production by Streptomyces hygroscopicus. J Ind Microbiol. 1996; 16:295-300.
59. White RJ, Lancini G. Production of rifamycin B. US Patent 3,871,965, 1975.
60. Young TB. Fermentation scale up: industrial experience with a total environmental approach. Ann N Y Acad Sci. 1979;326:165-180.